A major focus of our lab is to investigate the molecular pathogenesis of organelle stress-mediated kidney diseases, to discover endoplasmic reticulum (ER) stress biomarkers, and to develop highly-targeted therapies by employing high-throughput drug screening.
Another focus is renal angiogenesis and fibrosis.
Dr. Chen in the News:
- Researchers Identify Novel Drug Target for Treatment of Nephrotic Syndrome
- Dr. Maggie Chen Receives UAB-UCSD O’Brien Center Pilot Award
- New Nanotechnique Monitors ER Stress Biomarker for ADTKD
- Dr. Ying Maggie Chen to Present at the 2021 FASEB ER Virtual Conference
- Ying Maggie Chen to Speak at Yale Symposium
- Ying Maggie Chen to Serve on ASN Grants Review Committee
- Ying Maggie Chen Appointed to FACA Nephrology Subcommittee
- Ying Maggie Chen Awarded NU GoKidney Grant
- Dr. Maggie Chen Receives $1.8M Department of Defense Grant to Develop Treatment for FSGS
- Dr. Ying Maggie Chen Awarded $300K Mallinckrodt Challenge Grant
- Ying Maggie Chen Receives Center for Drug Discovery Investigator Matching Grant
- Dr. Maggie Chen and Yeawon Kim Honored at OTM’s Annual Celebration of Inventors